DME Microaneurysm changes Enlarged FAZ Zone Capillary non perfusion zone Central-
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients diagnosed with Diabetic Macular Edema (DME). - Age > 18 years of age who have signed an inform consent. - Candidates to be treated with Intravitreous Anti-VEGF ( Aflibercept , Bevacizumab and Ranibizumab ) - No history of Anti-VEGF treatment within 3 months. - No history of retina surgery.
Exclusion criteria
Exclusion criteria: - Presence of severe media opacities. - Patients who have other disease: monoculus, eye injuries , glaucoma, uveitis, retinal vein occlusion, retinal arterial occlusion, hereditary and degenerative macular disease, retinal and choroidal detachment. - Any previous treatment for DME e.g. Focal / Grid LASER , IVT steroid injection/implant with in 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MIcroaneurysm in ETDRS Grid 1 year Image J Software | — |
Secondary
| Measure | Time frame |
|---|---|
| FAZ 1 year Image J ,Capillary non perfusion area 1 year Image J | — |
Contacts
Faculty of Medicine, Chulalongkorn University